The expanding role of semaglutide in cardiovascular disease and its the effect on blood pressure

Back

ESC Professional Premium Access

The expanding role of semaglutide in cardiovascular disease and its the effect on blood pressure

Session: Hypertension management: drugs

Topic: Pharmacotherapy

Speaker: Doctor C. Kennedy (Dublin, IE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Cormac Kennedy

Trinity College Dublin, Dublin (Ireland)

1 follower

7 more presentations in this session

Systolic plood pressure response to ASi BI 690517 with and without empagliflozin in CKD

Speaker: Professor P. Rossing (Herlev, DK)

Adherence to anti-hypertensive therapy with perindopril-based single-pill versus free-pill combinations: a 10-year real-world analysis in Italy

Speaker: Associate Professor A. Vintila (Bucharest, RO)

Real-world analysis exploring the association between anti-hypertensive therapy with perindopril-based single-pill combinations (SPC) and cardiovascular outcomes and all-cause mortality in Italy

Speaker: Associate Professor J. Wolf (Gdansk, PL) Doctor S. Masi (Pisa, IT)

Injectable angiotensinogen inhibition therapy for hypertension: a systematic review and meta-analysis

Speaker: Doctor A. Yadav (New Delhi, IN)

A higher adherence to perindopril-based anti-hypertensive therapy is associated with a reduced risk of cardiovascular outcomes and all-cause mortality in real clinical practice in Italy

Speaker: Doctor S. Masi (Pisa, IT)

Access the full session

Hypertension management: drugs

Speakers: Doctor C. Kennedy, Professor P. Rossing, Associate Professor A. Vintila, Associate Professor J. Wolf, Doctor S. Masi...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources